These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22069048)

  • 1. [The enteric glia--part of the puzzle in Crohn's disease?].
    von Boyen G; Reinshagen M
    Z Gastroenterol; 2011 Nov; 49(11):1482-6. PubMed ID: 22069048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of enteric glia in gut inflammation.
    von Boyen G; Steinkamp M
    Neuron Glia Biol; 2010 Nov; 6(4):231-6. PubMed ID: 21774866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal integrity and barrier function in the pathogenesis of early lesions in Crohn's disease.
    Sanders DS
    J Clin Pathol; 2005 Jun; 58(6):568-72. PubMed ID: 15917403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concept of Crohn's disease being conditioned by four main components, and irritable bowel syndrome being an incomplete Crohn's disease.
    Olbe L
    Scand J Gastroenterol; 2008; 43(2):234-41. PubMed ID: 17918000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased gastric and intestinal permeability in patients with Crohn's disease.
    Wyatt J; Oberhuber G; Pongratz S; Püspök A; Moser G; Novacek G; Lochs H; Vogelsang H
    Am J Gastroenterol; 1997 Oct; 92(10):1891-6. PubMed ID: 9382060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.
    Sartor RB
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):390-407. PubMed ID: 16819502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical study of the enteric glia in chronic intestinal inflammatory disease].
    Bongioanni P; Castagna M; Morisi M
    Minerva Med; 1996; 87(7-8):323-9. PubMed ID: 8975170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enteric glial cells. An upstream target for induction of necrotizing enterocolitis and Crohn's disease?
    Bush TG
    Bioessays; 2002 Feb; 24(2):130-40. PubMed ID: 11835277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal healing in Crohn's disease and ulcerative colitis: what does it tell us?
    Flynn A; Kane S
    Curr Opin Gastroenterol; 2011 Jul; 27(4):342-5. PubMed ID: 21378560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healing the mucosa in Crohn's disease: does it matter?
    Ling KL; Chuah SW; Kong SC
    Singapore Med J; 2013 Apr; 54(4):185-9. PubMed ID: 23624443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterisation of decoy receptor 3 in Crohn's disease.
    Funke B; Autschbach F; Kim S; Lasitschka F; Strauch U; Rogler G; Gdynia G; Li L; Gretz N; Macher-Goeppinger S; Sido B; Schirmacher P; Meuer SC; Roth W
    Gut; 2009 Apr; 58(4):483-91. PubMed ID: 19039087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease.
    Baert F; Moortgat L; Van Assche G; Caenepeel P; Vergauwe P; De Vos M; Stokkers P; Hommes D; Rutgeerts P; Vermeire S; D'Haens G; ;
    Gastroenterology; 2010 Feb; 138(2):463-8; quiz e10-1. PubMed ID: 19818785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in E-cadherin (CDH1) result in a mis-localised cytoplasmic protein that is associated with Crohn's disease.
    Muise AM; Walters TD; Glowacka WK; Griffiths AM; Ngan BY; Lan H; Xu W; Silverberg MS; Rotin D
    Gut; 2009 Aug; 58(8):1121-7. PubMed ID: 19398441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
    Eriksson A; Jennische E; Flach CF; Jorge A; Lange S
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunopathological studies of the small intestinal intramural nervous system and of intramural vessels in Crohn's disease.
    Geboes K
    Verh K Acad Geneeskd Belg; 1993; 55(4):267-301; discussion 301-3. PubMed ID: 8128776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease.
    Suenaert P; Bulteel V; Lemmens L; Noman M; Geypens B; Van Assche G; Geboes K; Ceuppens JL; Rutgeerts P
    Am J Gastroenterol; 2002 Aug; 97(8):2000-4. PubMed ID: 12190167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
    Rutgeerts P; Diamond RH; Bala M; Olson A; Lichtenstein GR; Bao W; Patel K; Wolf DC; Safdi M; Colombel JF; Lashner B; Hanauer SB
    Gastrointest Endosc; 2006 Mar; 63(3):433-42; quiz 464. PubMed ID: 16500392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrier dysfunction and bacterial uptake in the follicle-associated epithelium of ileal Crohn's disease.
    Keita AV; Söderholm JD
    Ann N Y Acad Sci; 2012 Jul; 1258():125-34. PubMed ID: 22731725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab.
    Laharie D; Reffet A; Belleannée G; Chabrun E; Subtil C; Razaire S; Capdepont M; de Lédinghen V
    Aliment Pharmacol Ther; 2011 Mar; 33(6):714-21. PubMed ID: 21235604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperplastic-like mucosal change in Crohn's disease: an unusual form of dysplasia?
    Kilgore SP; Sigel JE; Goldblum JR
    Mod Pathol; 2000 Jul; 13(7):797-801. PubMed ID: 10912940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.